NCT05784324 is a clinical trial of No intervention in The Focus of the Study is Shift Work, sponsored by Oslo Metropolitan University.

Who is sponsoring NCT05784324?

NCT05784324 is sponsored by Oslo Metropolitan University.

What drugs are being tested in NCT05784324?

Interventions in NCT05784324: No intervention.

What condition does NCT05784324 study?

NCT05784324 studies The Focus of the Study is Shift Work.

Is NCT05784324 still recruiting?

NCT05784324 is currently not yet recruiting. Last updated 24 March 2023.

Last reviewed 2023-03-24 · How we verify

NCT05784324

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COMPRESSED - A Longitudinal Study of Compressed Work Schedules Within the Health, Care and Welfare Services

Not yet recruiting Last updated 24 March 2023

What this trial tests

trial testing No intervention in The Focus of the Study is Shift Work in 700,000 participants. Not yet recruiting.

Timeline

1 June 2023

Primary endpoint
1 February 2025

12 December 2027

Quick facts

Lead sponsor	Oslo Metropolitan University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	700,000
Start date	1 June 2023
Primary completion	1 February 2025
Estimated completion	12 December 2027

Drugs / interventions tested

No intervention

Conditions studied

The Focus of the Study is Shift Work — all drugs for The Focus of the Study is Shift Work →

Sponsor

Oslo Metropolitan University

Who can join

Eligibility, any sex, with The Focus of the Study is Shift Work. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of COMPRESSED is to investigate the potential consequences of a compressed work schedule within the municipal health, care and welfare services.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other Oslo Metropolitan University trials

Trials by the same sponsor.

NCT06578260 — Support Groups - a Model for Social Inclusion and Reduction of Bullying in School · NA · recruiting
NCT05895604 — The Mother in Norway Study · NA · recruiting
NCT06117098 — Mobile App for Risk Reduction of Type 2 Diabetes · NA · unknown
NCT05697120 — Long-term Effects of Individualized Follow-up With an App for One Year · completed
NCT05919355 — Effectiveness of a Communication Device in Home Care Services in Norway: Does Komp Make Older Adults Feel Happier, Safer · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05784324 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo Metropolitan University
Last refreshed: 24 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05784324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing